CV THERAPEUTICS INC·4

Apr 29, 4:03 PM ET

CV THERAPEUTICS INC 4

4 · CV THERAPEUTICS INC · Filed Apr 29, 2008

Insider Transaction Report

Form 4
Period: 2008-04-25
BLACKBURN BRENT K
SVP, Drug Discovery & Dev
Transactions
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2008-04-2512,50012,500 total
    Exercise: $5.81From: 2000-02-19Exp: 2009-02-19Common Stock (12,500 underlying)
  • Exercise/Conversion

    Common Stock

    2008-04-25$5.81/sh+12,500$72,62548,795 total
  • Sale

    Common Stock

    2008-04-25$9.51/sh12,500$118,87536,295 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    5,051.908
Footnotes (5)
  • [F1]The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2007.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2007.
  • [F3]Shares held in the Reporting Person's name by the Issuer's 401(k) plan. Includes Company 401(k) match of 1,769 shares of common stock to the Reporting Person on January 10, 2008.
  • [F4]The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2007.
  • [F5]The shares subject to this grant were fully vested as of February 19, 2003.

Documents

1 file
  • 4
    rrd204501.xmlPrimary

    BLACKBURN FORM 4 APRIL 25, 2008 PER 10B5-1 TRADING PLAN